Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA

T Kim1, T Murakami, Y Hasuike

  • 1Department of Radiology, Osaka University Medical School, Japan.

Journal of Magnetic Resonance Imaging : JMRI
|July 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Semidiscoid lateral meniscus].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

[Abnormal chest shadow on CT in immunosuppressed patients].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

[MR imaging evaluation of plica synoviallis mediopatellaris of the knee joint].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

Structure-activity relationships of mu-conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations.

Biochemistry·1992
Same author

Tumor necrosis factor modulation of expression of the cystic fibrosis transmembrane conductance regulator gene.

FEBS letters·1992
Same author

Inhibition of passive cutaneous anaphylaxis by synthetic human immunoglobulin E peptide fragments.

FEBS letters·1992

This study explores how a specific contrast agent used in magnetic resonance imaging can help doctors measure how well the liver is working. By testing rats with chemically induced liver damage, researchers found that the agent's behavior in the liver changes predictably as damage increases. This suggests that this imaging technique could become a reliable, non-invasive way to assess liver health in the future.

Area of Science:

  • Diagnostic radiology and Gd-EOB-DTPA imaging applications
  • Hepatology research within clinical medicine

Background:

Liver health assessment remains a challenge in clinical practice due to the limitations of current diagnostic tools. Many existing methods require invasive procedures that carry risks for patients. Researchers have sought non-invasive alternatives to accurately gauge organ performance. This gap motivated the investigation into specialized contrast agents for imaging. Prior work established that certain molecules accumulate in healthy liver cells. That uncertainty drove the need to test these agents in damaged models. No prior work had resolved whether these markers could quantify varying levels of injury. This study addresses how imaging signals correlate with established markers of impaired function.

Purpose Of The Study:

The study aims to determine if a specific contrast agent can effectively measure liver performance. Researchers sought to evaluate whether this substance could distinguish between healthy and damaged tissue. They focused on identifying a non-invasive method to quantify the extent of hepatic injury. The motivation stemmed from the need for safer diagnostic alternatives to traditional blood-based assessments. By utilizing chemically induced models, the team aimed to establish a clear relationship between imaging signals and organ health. They hypothesized that the contrast agent would behave differently in impaired livers. This work addresses the lack of reliable, real-time imaging tools for assessing metabolic function. The authors intended to provide a foundation for future clinical applications of this diagnostic technique.

Keywords:
hepatitis animal modelsliver enhancementT1-weighted imagingcontrast agent efficacy

Frequently Asked Questions

The researchers observed that liver enhancement decreased while contrast washout times increased in damaged models. This mechanism occurs because the agent relies on functional uptake by hepatocytes, which is impaired during chemically induced injury. Unlike healthy tissue, damaged livers show significantly reduced signal intensity on T1-weighted images.

The study utilized carbon tetrachloride to induce varying degrees of hepatitis in rats. This chemical agent creates a dose-dependent model of injury, allowing researchers to compare imaging results against standard serologic tests and prothrombin time measurements. Control groups provided a baseline for normal liver function.

The T1-weighted spin-echo sequence is necessary because it captures the signal intensity changes caused by the contrast agent. By measuring these signals before and up to 60 minutes after injection, the team could track how the liver processes the substance over time.

Related Experiment Videos

Main Methods:

The investigation employed a controlled animal model to assess imaging performance. Investigators divided subjects into three distinct groups based on varying chemical exposure levels. They administered carbon tetrachloride to induce controlled injury in two groups. A third group served as the healthy baseline for comparison. The team utilized T1-weighted spin-echo sequences to capture liver signals. They monitored these signals continuously for one hour post-injection. Researchers also performed standard blood tests to verify the degree of organ impairment. This approach allowed for a direct comparison between imaging data and established physiological markers.

Main Results:

The strongest finding demonstrates that liver enhancement levels are directly linked to the severity of chemical injury. Data revealed that higher doses of the damaging agent resulted in significantly lower signal intensity. The study also showed that contrast washout times were prolonged in the damaged groups. These observations were consistent across all subjects receiving the chemical intervention. The researchers confirmed that both dysfunction and enhancement follow a dose-dependent pattern. Comparisons with serologic tests and prothrombin time confirmed the imaging accuracy. The results highlight a clear inverse relationship between tissue health and contrast uptake. This pattern provides a quantitative basis for evaluating organ performance through non-invasive scans.

Conclusions:

The authors suggest that this imaging agent provides a viable pathway for assessing liver performance. Their findings indicate that signal changes correlate directly with the severity of tissue injury. This synthesis implies that clinicians might soon rely on non-invasive scans for diagnostic purposes. The researchers propose that the observed contrast behavior reflects specific cellular uptake deficits. Their work highlights the potential for reducing reliance on traditional blood-based tests. The study demonstrates that signal intensity patterns serve as reliable indicators of organ status. These results support the integration of this technique into broader diagnostic workflows. Future applications may refine how practitioners interpret these specific imaging signatures in diverse clinical settings.

The indocyanine green test serves as a gold-standard reference for liver clearance capacity. By comparing this data with MRI enhancement patterns, the authors validated that their imaging approach accurately reflects the actual physiological state of the organ. This correlation strengthens the reliability of the new diagnostic tool.

The researchers measured the degree of liver enhancement and the duration of contrast washout. They found that both metrics were dose-dependent, meaning the severity of the chemical injury directly dictated the intensity and timing of the signal observed on the scans.

The authors propose that this imaging method could eventually replace more invasive diagnostic procedures. They claim that the technique offers a non-invasive way to monitor organ health, potentially improving patient outcomes by providing earlier and more accurate assessments of liver function compared to traditional blood tests.